Literature DB >> 15808886

Downregulation of Rac1 activation by caffeic acid in aortic smooth muscle cells.

Jin-Wen Xu1, Katsumi Ikeda, Akira Kobayakawa, Takao Ikami, Yasuyo Kayano, Takahiko Mitani, Yukio Yamori.   

Abstract

Caffeic acid, a dietary phenol from coffee, fruits and vegetables, is an efficient antioxidant. However, little is known about its anti-oxidative mechanism in the modulation of fundamental cellular processes. In this study, we investigated whether caffeic acid regulates Rac1 GTPase activity, a partner of NADPH oxidase. Our results showed that caffeic acid decrease Rac1 protein level under basal conditions and incubation with angiotensin II (ANG II) in vascular smooth muscle cells. In a Rac-bound-to-PAK pull down assay, caffeic acid clearly inhibited Rac1 activity. We also observed that caffeic acid suppressed the generation of superoxide anion stimulated by ANG II that activates NADPH oxidase. On the other hand, co-incubation with caffei caid and cycloheximide significantly accelerated the Rac1 degradation. In addition, pretreatment with caffeic acid for 24 hours was able to prevent phosphorylation of MLC and HSP27, when cells were challenged with ANG II through the redox sensitive pathway. These results support the hypothesis that caffeic acid reduces Rac1 GTPase protein and activity level, followed by a down-regulation of NADPH oxidase activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808886     DOI: 10.1016/j.lfs.2004.11.015

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Activity of caffeic acid phenethyl ester in Caenorhabditis elegans.

Authors:  Jeffrey J Coleman; Tomomi Komura; Julia Munro; Michael P Wu; Rakhee R Busanelli; Angela N Koehler; Méryl Thomas; Florence F Wagner; Edward B Holson; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-10-14       Impact factor: 3.808

Review 2.  Can natural products modulate cytokine storm in SARS-CoV2 patients?

Authors:  Doha H Abou Baker
Journal:  Biotechnol Rep (Amst)       Date:  2022-06-09

Review 3.  The antiviral and immunomodulatory activities of propolis: An update and future perspectives for respiratory diseases.

Authors:  Andrea Magnavacca; Enrico Sangiovanni; Giorgio Racagni; Mario Dell'Agli
Journal:  Med Res Rev       Date:  2021-11-02       Impact factor: 12.388

4.  Chemical evolution for taming the 'pathogenic kinase' PAK1.

Authors:  Hiroshi Maruta; Atsushi Kittaka
Journal:  Drug Discov Today       Date:  2020-04-26       Impact factor: 7.851

Review 5.  Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle.

Authors:  Kanika Khanna; Sukhmeen Kaur Kohli; Ravdeep Kaur; Abhay Bhardwaj; Vinay Bhardwaj; Puja Ohri; Anket Sharma; Ajaz Ahmad; Renu Bhardwaj; Parvaiz Ahmad
Journal:  Phytomedicine       Date:  2020-10-03       Impact factor: 5.340

6.  The use of standardized Brazilian green propolis extract (EPP-AF) as an adjunct treatment for hospitalized COVID-19 patients (BeeCovid2): a structured summary of a study protocol for a randomized controlled trial.

Authors:  Marcelo Augusto Duarte Silveira; Sergio Pinto de Souza; Erica Batista Dos Santos Galvão; Maurício Brito Teixeira; Marcel Miranda Dantas Gomes; Lucas Petri Damiani; Bruno Andrade Bahiense; Julia Barros Cabral; Cicero Wandson Luiz Macedo De Oliveira; Talita Rocha Mascarenhas; Priscila Carvalho Guedes Pinheiro; Milena Souza Alves; Rodrigo Morel Vieira de Melo; Andresa Aparecida Berretta; Flávia Mendes Leite; Carolina Kymie Vasques Nonaka; Bruno Solano de Freitas Souza; Ana Verena Almeida Mendes; Suzete Farias da Guarda; Rogério da Hora Passos
Journal:  Trials       Date:  2022-04-04       Impact factor: 2.728

Review 7.  In silico evaluation of Vitis amurensis Rupr. Polyphenol compounds for their inhibition potency against COVID-19 main enzymes Mpro and RdRp.

Authors:  Imen Souid; Atef Korchef; Safouan Souid
Journal:  Saudi Pharm J       Date:  2022-02-25       Impact factor: 4.562

Review 8.  COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development.

Authors:  Joowon Yim; Hee Hyun Lim; Youngjoo Kwon
Journal:  Arch Pharm Res       Date:  2021-05-28       Impact factor: 6.010

9.  PAK in pathogen-host interactions.

Authors:  Jean-Philippe Semblat; Christian Doerig
Journal:  Cell Logist       Date:  2012-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.